FDA-Inspected Site

ACS Dobfar SpA

5 FDA inspections are on record for ACS Dobfar SpA in Verona, Italy.

483· Form 483 issued

Verona, Italy · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2018-06-19.

At a glance

Inspections

5

Form 483s

4

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Jun 2018 – 19 Jun 2018Human Drugs483View 483 →
12 May 2016 – 20 May 2016Human Drugs483On file
10 Mar 2014 – 18 Mar 2014Human Drugs483View 483 →
8 Jul 2011Not recordedClean
21 Jan 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

19 Jun 2018
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Rachael A Moliver, Katie L Penno

18 Mar 2014
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.170(b)

Reserve samples identified, representative, stored

Cited by Noreen Muniz

Investigators

FDA investigators tied to this site in the record.

Constance Y Fears1 insp.
Edwin Melendez1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind ACS Dobfar SpA's 4 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat